NotíciasÚltima atualização: Terça-feira, 03 de Setembro de 2024

Elisa Acitelli   et al. | Endocrine 2024; 85(1): 122-33
Familial hypercholesterolemia (FH) is one of the most common autosomal dominant genetic diseases, characterized...
Sayaka Funabashi MD et al. | Journal of the American Heart Association...
A total of 13.6% of Japanese subjects with heterozygous familial hypercholesterolemia had asymptomatic...
Sibbeliene E. van den Bosch et al. | European Journal of Pediatrics 2024;...
Heterozygous familial hypercholesterolemia (FH) is the most common monogenic disorder of cholesterol...
Minako Matsumoto et al. | Pharmacoepidemiology and Drug Safety...
Medication adherence and factors associated with non‐adherence among prevalent users were evaluated...
Rafael Zubirán   et al. | Diabetes Therapy 2024; 15(9): 1979-2000...
Primary hyperlipidemias are a group of monogenic and polygenic diseases characterized by severe disorders...
Qiu Weiqing et al. | Cancer & Metabolism 2024; 12(1): 14
The association between obesity and increased colorectal cancer (CRC) incidence has been evaluated in...
Kim Hae Jin et al. | Advances in Therapy 2024; 41(8): 3119-37...
Statins [3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA) inhibitors] are used as first-line...
Zicheng Wang MS et al. | Journal of the American Heart Association...
This is the first study to combine novel saliva metabolites and more commonly used plasma metabolites...
Du Yanbin et al. | Journal of Health, Population and Nutrition...
Cardiovascular disease (CVDs) is the leading cause of death globally, 17 million people die to CVDs...
Natália Baltazar Nascimento et al. | Alzheimer's & dementia : the journal...
Low‐density lipoprotein (LDL) is responsible for the transport of cholesterol to peripheric tissues...

Pesquisa bibliográficaAlvo e aperfeiçoe sua pesquisa de informações médicas

Pesquisa por revista
1071 artigos disponíveis
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9

Top artigosOs 5 artigos mais lidos pelos leitores

Du Yanbin et al. | Journal of Health, Population and Nutrition...
Cardiovascular disease (CVDs) is the leading cause of death globally, 17 million people die to CVDs each year and it is estimated to reach 24.8 million deaths in 2030 in the world [1]. Dyslipidemia...
Elisa Acitelli   et al. | Endocrine 2024; 85(1): 122-33
Familial hypercholesterolemia (FH) is one of the most common autosomal dominant genetic diseases, characterized by an increased exposure to elevated low-density lipoprotein cholesterol (LDL-C) levels that...
Minako Matsumoto et al. | Pharmacoepidemiology and Drug Safety...
Medication adherence and factors associated with non‐adherence among prevalent users were evaluated in a population‐based cohort study. Adherence differed by treatment status (hypertension,...
Qiu Weiqing et al. | Cancer & Metabolism 2024; 12(1): 14
The association between obesity and increased colorectal cancer (CRC) incidence has been evaluated in several epidemiological studies [1]. However, studies have not been able to determine which metabolic...
Kim Hae Jin et al. | Advances in Therapy 2024; 41(8): 3119-37...
Statins [3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA) inhibitors] are used as first-line treatment for patients with dyslipidemia, aiding in the prevention and management of cardiovascular...